Prosecution Insights
Last updated: October 04, 2026

Evercorn Inc.

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Evercorn Inc. currently has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This action is assigned to 1 distinct examiner, BRANDSEN, BENJAMIN MICHAEL, who is also the busiest examiner for the portfolio with 1 pending office action. The prosecution is localized in 1 distinct art unit, indicating a concentrated focus on a specific area of biotechnology. For practitioners, this means the entire current workload is subject to the interpretation of a single examiner. This centralized structure allows for a very specific and tailored prosecution strategy.

The presence of 1 distinct art unit suggests that the company's current patent efforts are not fragmented across different examination groups. Because BRANDSEN, BENJAMIN MICHAEL is the only examiner involved, the applicant can focus on addressing this individual's specific concerns and preferences. In the Biotechnology & Pharmaceuticals field, where examination can be particularly detailed, having only 1 pending office action allows for a high degree of focus. The administrative overhead for managing this portfolio is limited, as there is only 1 pending office action to monitor. This allows the legal team to dedicate more time to the technical merits of the single application.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
0
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
BRANDSEN, BENJAMIN MICHAEL 1 60.2% +18.6%

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18227663 BIO-BASED STARCH MIXED ESTER BIODEGRADABLE AND/OR COMPOSTABLE COMPOSITIONS AND METHODS FOR MAKING THE SAME BRANDSEN, BENJAMIN MICHAEL —

Top Art Units

Art UnitApps
1693 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18227663 BIO-BASED STARCH MIXED ESTER BIODEGRADABLE AND/OR COMPOSTABLE COMPOSITIONS AND METHODS FOR MAKING THE SAME BRANDSEN, BENJAMIN MICHAEL 1693 §103Other Final Rejection — Pending Jul 28, 2023

Managing Evercorn Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month